A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating. Around 70,000 people die each year from infections with the hepatitis E virus.
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver ...
The worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, has stimulated intensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results